Trade Rockwell Medical, Inc. - RMTI CFD
Add to favourite- Summary
- Historical Data
Spread | 0.09 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 1.85 |
Open | 1.79 |
1-Year Change | -48.27% |
Day's Range | 1.79 - 1.93 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 26, 2024 | 1.87 | 0.08 | 4.47% | 1.79 | 1.93 | 1.79 |
Jul 25, 2024 | 1.82 | -0.01 | -0.55% | 1.83 | 1.88 | 1.79 |
Jul 24, 2024 | 1.86 | -0.02 | -1.06% | 1.88 | 1.90 | 1.81 |
Jul 23, 2024 | 1.92 | 0.02 | 1.05% | 1.90 | 1.94 | 1.84 |
Jul 22, 2024 | 1.91 | 0.05 | 2.69% | 1.86 | 1.95 | 1.86 |
Jul 19, 2024 | 1.89 | 0.03 | 1.61% | 1.86 | 1.93 | 1.86 |
Jul 18, 2024 | 1.87 | -0.04 | -2.09% | 1.91 | 1.99 | 1.84 |
Jul 17, 2024 | 1.99 | 0.01 | 0.51% | 1.98 | 2.03 | 1.89 |
Jul 16, 2024 | 2.03 | -0.06 | -2.87% | 2.09 | 2.11 | 1.97 |
Jul 15, 2024 | 2.12 | 0.04 | 1.92% | 2.08 | 2.13 | 2.00 |
Jul 12, 2024 | 2.07 | -0.14 | -6.33% | 2.21 | 2.24 | 2.03 |
Jul 11, 2024 | 2.07 | 0.11 | 5.61% | 1.96 | 2.15 | 1.94 |
Jul 10, 2024 | 1.91 | 0.11 | 6.11% | 1.80 | 1.98 | 1.76 |
Jul 9, 2024 | 1.79 | 0.03 | 1.70% | 1.76 | 1.86 | 1.73 |
Jul 8, 2024 | 1.80 | 0.11 | 6.51% | 1.69 | 1.80 | 1.69 |
Jul 5, 2024 | 1.68 | -0.03 | -1.75% | 1.71 | 1.71 | 1.64 |
Jul 3, 2024 | 1.73 | 0.10 | 6.13% | 1.63 | 1.74 | 1.63 |
Jul 2, 2024 | 1.67 | 0.02 | 1.21% | 1.65 | 1.68 | 1.63 |
Jul 1, 2024 | 1.65 | -0.04 | -2.37% | 1.69 | 1.74 | 1.65 |
Jun 28, 2024 | 1.72 | 0.01 | 0.58% | 1.71 | 1.72 | 1.63 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Rockwell Medical, Inc. Company profile
About Rockwell Medical Inc
Rockwell Medical, Inc. is a commercial-stage, biopharmaceutical company. The Company is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. It is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The Company has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Rockwell Medical Inc revenues decreased 1% to $46.6M. Net loss increased 7% to $23.7M. Revenues reflect United States segment decrease of 1% to $41.9M. Higher net loss reflects Research and Product Development increase of 5% to $5.4M (expense), Interest Income decrease of 92% to $18K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.32 to -$0.25.
Equity composition
Common Stock no Par, 04/11, N/A auth., 17,843,608 issd. Insiders control 14.55%. IPO:1/98,1.8M Common @ $4 + 2.7M Warrants @ $.10 by Mason Hill & Co., Inc. *NOTE: FY'96 = 2 months due to 10/25/96 inception. All financials prior to 2/19/97 are Predecessor.
Industry: | Bio Therapeutic Drugs |
30142 Wixom Road
48393
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com